Form 8-K · Current Report · Filed 2025-01-28
Stryker Announces Retirement of CFO Glenn Boehnlein and Promotion of Preston Wells
On January 28, 2025, Stryker Corporation announced the retirement of its Vice President and Chief Financial Officer, Glenn S.
- Filer
- Stryker Corporation SYK · NYSE
- Filed
- Accession
- 0001193125-25-014415
- CIK
- 0000310764
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
Boehnlein, effective April 1, 2025. Preston W. Wells, currently serving as Vice President and Group Chief Financial Officer for Orthopaedics, will be promoted to Vice President and Chief Financial Officer in his place. Boehnlein will continue as an advisor to the CEO until March 31, 2026, and Wells will assume his new role on April 1, 2025.
Items reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$399.90
Next session
-2.2%
Since filing
-18.6%
Latest close
$325.70
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from SYK reporting the same item, with the next session's move:
Exhibits (3)
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Never miss another SYK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.